Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
About us

Publications

All →
The selection and use of essential medicines, 2025: WHO AWaRe (Access, Watch, Reserve) classification of antibiotics for evaluation and monitoring of use
5 September 2025

The selection and use of essential medicines, 2025: WHO AWaRe (Access, Watch, Reserve) classification...

he AWaRe classification is intended as a tool for monitoring antibiotic consumption, defining targets and monitoring the effects of stewardship policies...

Download
Read More
The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines for Children, 10th list
5 September 2025

The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines for Children,...

Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and...

Download
Read More
The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list
5 September 2025

The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list

Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and...

Download
Read More
The selection and use of essential medicines, 2025: report of the 25th WHO Expert Committee on Selection and Use of Essential Medicines, executive summary
5 September 2025

The selection and use of essential medicines, 2025: report of the 25th WHO Expert Committee on Selection...

This executive summary reports the recommendations made by the Expert Committee on Selection and Use of Essential Medicines for the 2025 update of the...

Download
Read More